There is no single CPT code designated specifically for bilateral breast ultrasound. The relevant codes, 76641 and 76642, are each defined as unilateral procedures, meaning they describe the exam of one breast at a time. When both breasts are imaged during the same visit, the appropriate code is reported twice, once per side, using modifiers to indicate laterality. The distinction between those two codes, and the correct way to bill them for a two-sided exam, trips up coders and billing staff regularly enough that it is worth walking through carefully.
The Two Breast Ultrasound Codes
Breast ultrasound falls under the soft tissue ultrasound category in the CPT system, and only two codes apply to diagnostic breast ultrasound imaging.
- 76641: Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; complete.
- 76642: Ultrasound, breast, unilateral, real time with image documentation, including axilla when performed; limited.
Both codes explicitly say “unilateral” in their descriptor, which is why there is no way to capture a bilateral exam with a single line on a claim.1PubMed Central. Billing I-AIM: a novel framework for ultrasound billing To report a bilateral breast ultrasound, you submit the same code twice with the appropriate laterality modifiers.
How to Report a Bilateral Exam
Two approaches are accepted for indicating that both breasts were examined. The first is to list the code on two separate claim lines, one with modifier -RT (right side) and one with modifier -LT (left side). The second is to list the code once with modifier -50 (bilateral procedure), which tells the payer the same service was performed on both sides. Which method a practice uses often depends on the payer. Some commercial insurers and Medicare Administrative Contractors prefer the two-line RT/LT approach because their claims-processing systems handle it more cleanly. Others accept modifier -50 without issue. Checking with the specific payer before submitting is the safest route, but RT/LT is generally the more universally accepted method and the one less likely to trigger an automatic denial.
One common mistake is appending modifier -50 and also listing the code on two lines. That combination can be read by automated claims systems as four units of the code rather than two, leading to either an overpayment that gets clawed back later or an immediate denial for exceeding reasonable frequency. The rule is simple: pick one method and use it consistently per payer.
Complete Versus Limited and When Each Applies
The difference between 76641 and 76642 is not about image quality or the equipment used. It is about the scope of the exam. A complete breast ultrasound (76641) surveys all four quadrants of the breast and the retroareolar region, with imaging of the axilla when clinically indicated. A limited exam (76642) targets a specific area, such as a palpable lump or an abnormality flagged on a prior mammogram, without scanning the entire breast.
In practice, which code applies depends on the clinical scenario, not on how long the exam takes. A screening-level ultrasound ordered for a patient with dense breast tissue who has no focal complaint is typically a complete study and gets 76641. A targeted look at a suspicious mass identified on mammography is a limited study and gets 76642. If a patient comes in for a targeted evaluation of one breast but the radiologist also performs a full screening survey of the other breast, the two sides can legitimately be coded differently: 76642-RT and 76641-LT, for example, or vice versa.
Mixing codes for the two sides is perfectly appropriate when the clinical documentation supports it, but the operative notes need to clearly describe what was done on each side. Vague documentation like “bilateral breast ultrasound performed” without specifying whether each side was a complete or limited study invites downcoding or denial on audit.
Why Bilateral Breast Ultrasound Orders Have Increased
The volume of bilateral breast ultrasound exams has grown substantially over the past decade, driven in large part by dense breast notification laws. As of 2024, the FDA requires mammography facilities nationwide to inform patients about their breast density, and many states have gone further by mandating that insurers cover supplemental screening for women with dense tissue. A large study of mammography data found that insurance coverage mandates were associated with roughly 47 additional ultrasound exams per 1,000 women screened, while notification-only laws produced a smaller but still measurable increase of about 13 additional exams per 1,000 women.2PubMed Central. Dense Breast Legislation and Supplemental Breast Imaging Among Women Undergoing Mammography
For billing departments, this trend means more bilateral 76641 claims. The typical supplemental screening scenario is a patient with heterogeneously or extremely dense breasts and a normal mammogram who is then referred for a whole-breast ultrasound of both sides. That is a complete bilateral exam: 76641 reported twice. Practices that were used to seeing mostly targeted, limited exams are now processing a higher proportion of complete bilateral studies and need their documentation workflows to match.
Documentation That Prevents Denials
Payers audit breast ultrasound claims more aggressively than many practices expect, partly because the bilateral coding structure creates opportunities for errors and partly because the rise in screening ultrasound volumes has drawn attention. A few documentation habits go a long way toward preventing problems.
First, the report should clearly state whether each breast received a complete or limited evaluation. Language like “all four quadrants and the retroareolar region of the right breast were surveyed” supports 76641. Language like “targeted evaluation of the 2 o’clock region of the left breast” supports 76642. If the axilla was evaluated on either or both sides, that should be documented as well, since both codes include axillary imaging “when performed” and the payer may want to see that the scope of work matched the code billed.
Second, the indication for the exam matters. For a screening bilateral ultrasound, the order should reference the patient’s breast density category and the clinical rationale, such as dense tissue on recent mammography with no focal abnormality. For a diagnostic bilateral ultrasound, the indication should reference the specific finding being investigated. If the exam starts as diagnostic on one side and the clinician decides to screen the other side during the same encounter, the documentation should say so explicitly rather than lumping both sides under a single generic indication.
Third, image documentation requirements are real. Each code requires real-time imaging with stored images. The number of images expected for a complete versus limited study is not specified in the CPT descriptor, but most accreditation bodies and payer policies expect a complete exam to include representative images from each quadrant and the retroareolar area. A complete bilateral exam with only four stored images total is likely to attract questions on review.
Modifier -59 and the Same-Session Mammogram Question
A common billing scenario is a patient who gets a mammogram and a bilateral breast ultrasound on the same day. In most cases, the ultrasound codes and the mammography codes (77065 for unilateral diagnostic mammography, 77066 for bilateral diagnostic, 77067 for bilateral screening) are not bundled together by the National Correct Coding Initiative, so they can be billed together without a special modifier. However, some payers have their own bundling edits that differ from the national standard. When a claim for same-day mammography and bilateral ultrasound gets denied as a bundled service, modifier -59 (distinct procedural service) or its more specific sub-modifiers (-XS, -XE, -XP, -XU) may be needed to indicate that the ultrasound was a separate, medically necessary study and not a duplicate of the mammogram.
The key is to avoid reflexively slapping -59 on every claim. That modifier has an audit target on it because it is so frequently misused. Only append it when the payer’s own edits require it, and make sure the clinical documentation supports the medical necessity of both studies in the same session. A screening mammogram followed by a screening ultrasound for dense breasts is a straightforward clinical scenario that most payers will cover, but the order and the report need to tell that story clearly.
Screening Versus Diagnostic and How It Affects Payment
The CPT codes themselves do not distinguish between screening and diagnostic intent. A complete bilateral breast ultrasound is 76641 times two whether the purpose is screening a dense-breasted patient or evaluating a diagnostic concern. The screening-versus-diagnostic distinction instead shows up in how the claim is processed by the insurer, which is driven by the diagnosis codes attached to the claim and, in some cases, the ordering physician’s stated intent.
This matters because many insurance plans cover screening breast ultrasound with no patient cost-sharing when it is performed under a state mandate or the Affordable Care Act’s preventive services provisions, but apply a deductible and copay to a diagnostic ultrasound. The same 76641 code, for the same exam, can result in different out-of-pocket costs depending on whether the claim carries a screening or diagnostic diagnosis code. Patients often do not understand this distinction, and practices get caught in the middle when a patient expects a zero-cost screening but the payer processes it as diagnostic because the attached ICD-10 code referenced a specific finding rather than a routine screening indication.
Getting this right requires attention at the front end of the workflow. When the ordering provider sends a patient for a bilateral screening ultrasound, the order should carry a screening-appropriate diagnosis code, typically Z12.31 (encounter for screening mammogram for malignant neoplasm of breast) along with a breast density code such as N63.0 if applicable. When the purpose is diagnostic, the diagnosis code should reflect the specific clinical concern. Mixing these up in either direction creates problems: a screening code on a diagnostic study can be denied for lack of medical necessity, while a diagnostic code on a screening study sticks the patient with unexpected cost-sharing.
When the Axilla Gets Its Own Code
Both 76641 and 76642 include axillary imaging “when performed,” which means a survey of the axillary lymph nodes done as part of the breast ultrasound is bundled into the breast code and does not generate an additional charge. However, there are clinical situations where the axilla is evaluated as a standalone study, separate from a breast ultrasound. In those cases, the appropriate code is 76882 (ultrasound, extremity, nonvascular, real time with image documentation; limited, anatomic specific) rather than a breast code, and it can be reported alongside 76641 or 76642 if the documentation supports a distinct clinical indication for the axillary evaluation beyond what the breast code covers.
This comes up most often in patients with known breast cancer who are undergoing ultrasound-guided evaluation of axillary nodes as a separate procedure from their breast imaging. It also arises when a palpable axillary mass is the primary clinical concern rather than a breast abnormality. In routine screening or diagnostic breast ultrasound, though, the axillary imaging is part of the breast code and should not be billed separately. Unbundling the axilla from the breast exam when they are performed together for the same indication is a compliance risk that auditors specifically look for.
Ultrasound-Guided Procedures Are Coded Separately
If a bilateral breast ultrasound identifies a suspicious finding and an ultrasound-guided biopsy is performed during the same session, the biopsy has its own set of CPT codes (19083 for the first lesion with ultrasound guidance, 19084 for each additional lesion). The imaging guidance is built into those procedure codes, so you do not also bill a separate 76942 (ultrasound guidance for needle placement) when 19083 or 19084 is reported. However, the diagnostic ultrasound that identified the lesion (76641 or 76642) is separately reportable from the biopsy as long as it was a distinct diagnostic study and not just the real-time guidance used during the procedure.
The practical scenario looks like this: a patient comes in, gets a complete bilateral breast ultrasound (76641-RT, 76641-LT), a suspicious mass is identified in the right breast, and an ultrasound-guided core biopsy is performed. The claim would include 76641-RT, 76641-LT, and 19083-RT. The diagnostic imaging and the interventional procedure are distinct services with distinct documentation, and they should be reported as such.
Facility Versus Professional Component
In a hospital outpatient or freestanding imaging center setting, 76641 and 76642 can be split into their technical component (modifier -TC, covering the equipment, technologist, and facility overhead) and professional component (modifier -26, covering the radiologist’s interpretation). The facility bills the TC and the interpreting physician bills the 26. In a physician’s office where the same entity owns the equipment and interprets the study, the code is billed globally with no modifier, capturing both components.
For bilateral exams, the split applies to each unit separately. A bilateral complete breast ultrasound in a hospital outpatient department generates four claim lines from two billing entities: the facility submits 76641-RT-TC and 76641-LT-TC, and the radiologist submits 76641-RT-26 and 76641-LT-26. Modifier stacking order can vary by payer, but laterality modifiers generally come before the component modifier. Checking the payer’s specific modifier-sequencing rules prevents unnecessary rejections at the claim-processing stage.